2019 LYFEBULB-UNITEDHEALTH GROUP: INNOVATION CHALLENGE IN DEPRESSION AND ANXIETY WINNER
About Rohan Dixit
Rohan Dixit is the founder of Lief Therapeutics, a smart patch that tracks and improves biomarkers of mental health. Formerly a Harvard and Stanford neuroscientist, his work has been featured on The Today Show, CNBC, The Atlantic, Rolling Stone, NBC, CBS and Forbes magazine.
"Rohan not only has a mission and purpose that aligned with the criteria of the challenge, but also has taken a conventional approach and reimagined it through the patient experience with evidence-based science behind it. Additionally, he has identified viable pathways to commercialization," commented Dennis Urbaniak, Chief Digital Officer of Havas Health & You, who served as Chair of the Jury.
LYFEBULB AND UNITEDHEALTH GROUP PRESENT EMPOWERING PATIENTS: AN INNOVATION CHALLENGE IN DEPRESSION AND ANXIETY
The 2019 Lyfebulb–UnitedHealth Group Innovation Challenge will recognize the top Patient Entrepreneurs developing innovative ideas for better management of depression and anxiety using healthcare information technology, medical devices, diagnostics, consumer products, or services. Patient Entrepreneurs are individuals with a chronic disease, or those who have a close relative or loved one with a chronic disease, who have founded or lead a company bringing innovative solutions to the market place.
JULY 23 & 24, 2019 AT UNITEDHEALTH GROUP
Deadline for applications was June 4, 2019 at 11:59pm EDT
Award & Judging Criteria
The award is open to Patient Entrepreneurs developing companies using healthcare information technology, medical devices, diagnostics, and/or consumer products or services that disrupt and shape the future care and management of patients with depression or anxiety.
You are eligible to apply for the 2019 Lyfebulb-UnitedHealth Group Innovation Challenge if:
- You work on innovative ideas and concepts for better care and management of depression or anxiety using healthcare information technology, medical devices, diagnostics, and/or consumer products or services; and
- You, or a family member or loved one, have lived with depression or anxiety; and
- Your idea is something other than a pharmaceutical or drug innovation.
WHAT ARE THE JUDGING CRITERIA?
The judging panel will look for evidence in the following categories:
- Patient Entrepreneur story
- Degree of innovation
- Impact on patient needs
- Feasibility of development and implementation into the marketplace
Why do patient entrepreneurs matter?
Because they are personally motivated by their own disease, or that of a loved one, Patient Entrepreneurs have a unique ability to create value-added solutions beyond therapy. Our aim is to support user-driven innovation and provide a laser-focus on solutions for providing a higher quality of life for those living with depression or anxiety.
Lyfebulb is a chronic disease-focused, patient empowerment platform that connects patients and industry (manufacturers and payers) to support user-driven innovation. Lyfebulb promotes a healthy, take-charge lifestyle for those affected by chronic disease. Grounded with its strong foundation in diabetes, the company has expanded disease states covered into cancer, inflammatory bowel disease, multiple sclerosis, and depression/anxiety.
UnitedHealth Group (NYSE: UNH) is a diversified health care company dedicated to helping people live healthier lives and helping to make the health system work better for everyone. UnitedHealth Group offers a broad spectrum of products and services through two distinct platforms: UnitedHealthcare, which provides health care coverage and benefits services; and Optum, which provides information and technology-enabled health services. For more information, visit UnitedHealth Group at unitedhealthgroup.com or follow @UnitedHealthGrp on Twitter.